Walleye Capital LLC Revance Therapeutics, Inc. Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 699,621 shares of RVNC stock, worth $1.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

699,621

Previous 49,100 1324.89%

Holding current value

$1.8 Million

Previous $126,000 1326.98%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.57 - $2.57 $228,290 - $228,290	88,829 Added 14.54%	699,621 $1.8 Million
Q2 2024 Aug 14, 2024	SELL	$2.34 - $4.73 $26,521 - $53,609	-11,334 Reduced 1.82%	610,792 $1.57 Million
Q1 2024 May 15, 2024	SELL	$4.65 - $9.31 $1.42 Million - $2.85 Million	-305,688 Reduced 32.95%	622,126 $3.06 Million
Q4 2023 Feb 14, 2024	BUY	$5.81 - $11.2 $3.61 Million - $6.97 Million	622,022 Added 203.41%	927,814 $8.16 Million
Q3 2023 Nov 14, 2023	BUY	$11.47 - $25.07 $2.2 Million - $4.81 Million	192,004 Added 168.74%	305,792 $3.51 Million
Q2 2023 Aug 14, 2023	SELL	$24.7 - $37.61 $4.11 Million - $6.26 Million	-166,574 Reduced 59.41%	113,788 $2.88 Million
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $4.19 Million - $8.05 Million	-228,333 Reduced 44.89%	280,362 $9.03 Million
Q4 2022 Feb 14, 2023	SELL	$18.32 - $30.66 $262,892 - $439,971	-14,350 Reduced 2.74%	508,695 $9.39 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $832,214 - $1.65 Million	58,075 Added 12.49%	523,045 $14.1 Million
Q2 2022 Aug 08, 2022	SELL	$11.52 - $20.4 $469,221 - $830,912	-40,731 Reduced 8.05%	464,970 $6.43 Million
Q1 2022 May 16, 2022	BUY	$12.36 - $20.31 $1.84 Million - $3.02 Million	148,464 Added 41.56%	505,701 $9.86 Million
Q4 2021 Mar 03, 2022	BUY	$12.46 - $27.87 $3.77 Million - $8.44 Million	302,760 Added 555.76%	357,237 $5.83 Million
Q3 2021 Nov 15, 2021	SELL	$25.78 - $33.21 $1.35 Million - $1.74 Million	-52,382 Reduced 49.02%	54,477 $1.52 Million
Q2 2021 Aug 16, 2021	BUY	$26.8 - $31.84 $981,148 - $1.17 Million	36,610 Added 52.11%	106,859 $3.17 Million
Q1 2021 May 17, 2021	SELL	$24.03 - $29.97 $26,817 - $33,446	-1,116 Reduced 1.56%	70,249 $1.96 Million
Q4 2020 Feb 16, 2021	BUY	$23.41 - $28.34 $1.67 Million - $2.02 Million	71,365 New	71,365 $2.02 Million
Q1 2019 May 15, 2019	SELL	$15.4 - $20.39 $271,717 - $359,761	-17,644 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$23.55 - $30.1 $415,516 - $531,084	17,644 New	17,644 $438,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Revance Therapeutics, Inc. Transaction History